Priority Areas in Life Sciences
Priority Areas in Life Sciences
Xeraya aspires to be an internationally reputable private equity and venture investor in all Life Sciences related areas, of which three are more prominent: medical technologies, healthcare biotech, bio renewables and bio industrials.
We view Life Sciences as an area to develop answers to the imperatives for the future:
Changing demographics
In a changing world with an ageing, better educated population, how can we best utilise greater collaborative R&D and cross-disciplinary technology, allied with the ubuiquity of 'big data' to deliver on increased healthcare needs and better standards of care?
Global climate change
How can we reduce the carbon footprint of human activities in energy, transportation, food production?
How do we move to biorenewables for energy, food and chemicals to lessen the environmental impact and realise value from waste material?
Food security
How do we feed the growing world population on scarce land with limited water—and how do we do it with minimal environmental impact?
While our definition of Medical Technologies (MedTech) is not indistinct from the generally accepted definition of medical and related products, we also include select Healthcare Services and Healthcare Information Technology in this category.

We seek entrepreneurs and companies with game changing technologies, and high IP protection potential. We tend not to be overly restrictive with disease states or geographic dimensions as our hospital affiliations through Khazanah are geographically diverse, catering to all forms of human ailments.
Healthcare Biotechnology in our parlance refers to the use of organic-based approaches and solutions to address Healthcare.

Thus, those approaches and technologies that rely on living organism and processes or applications thereof to provision healthcare directly or indirectly are also our area of focus. Examples include but are not limited to Stem Cells technologies, Genetics and Genomics, etc.
The use of biotechnology in developing renewables and displacing traditional industrial processes and practices using living organisms is what we categorize in this section. Bioplastics, biofuels, biochemicals, and similar areas are all examples of what we include in this category.

We do not focus on non-organic Renewable generation technologies that take advantage of natural resources such as those related to Solar or Wind. We are, however, active investors in, and strive to work with companies that use biomass as feedstock in developing their end products.
Our Portfolio